Philips Unveils AI-Powered Imaging Innovations and Expands Cloud Collaboration with AWS at RSNA 2024

Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24 - Koninklijke Philips (NYSE:PHG)

December 1, 2024 Philips' intelligent diagnostic and treatment solutions, combined with its advanced capabilities in healthcare informatics, uniquely position the company to drive precision imaging for a greater number of patients Amsterdam, the Netherlands and Chicago, USA - Royal Philips PHGPHIA), a global leader in health technology, today unveiled the company's latest AI-powered diagnostic and treatment imaging innovations to advance precise imaging with faster, easier and more efficient workflows. Addressing key challenges faced by radiologists, these innovations are complemented by Philips' industry-leading expertise in cloud-based data management, advanced visualization, automation, and AI. Together, they aim to reduce the administrative burden and empower clinicians with insights to deliver better care for more people. "The healthcare industry is facing a perfect storm of challenges in radiology: increasing patient volumes, skyrocketing demand for imaging studies, and an explosion in imaging data. At the same time, staff shortages are creating mounting pressure on already strained resources," said Bert van Meurs, Chief Business Leader of Diagnosis and Treatment at Philips. "Our intelligent imaging systems combined with our world-class informatics support healthcare providers in embracing innovative solutions that enhance efficiency, reduce the administrative burden, and empower radiologists to focus on delivering precise, high-quality care." The Philips Future Health Index 2024 Report shows 99% of radiology leaders surveyed struggle with staff shortages, with nearly 4 in 5 facing financial pressures, and 45% experiencing symptoms of burnout. Radiologists are also seeing a 40% increase in patients with complex diseases [1] in clinical areas like cardiology and neurology, which is driving the need for imaging exams and a 60% increase in imaging data [2]. At this year's RSNA, Philips will demonstrate how it is uniquely positioned to help mitigate these challenges with breakthrough innovations that advance precision imaging for more patients and enhance productivity through seamless integration of imaging and informatics. Leadership in innovative helium-free MRI operations Philips will unveil the industry's first and only wide-bore, high-performance helium-free [3] MR scanner with fully integrated cloud-based, AI-driven, automated quantitative reporting capabilities [4] for specific disease areas like neurology and oncology. With AI assistance at every step of the workflow, from planning to imaging and reporting, Philips' next generation BlueSeal 1.5T MRI boosts productivity, ease of use and access to precision diagnosis around the world, while caring for the planet. Philips' revolutionary BlueSeal technology sets new standards in MRI as the lightest 70 cm system available today [5], making it easier to install and cost-effective to maintain, enabling flexible installations and wider access in new locations. Breakthrough innovations in Diagnosis and Treatment Making its debut in North America at RSNA is the fully AI-enabled CT 5300, featuring Precise Image AI-based reconstruction software to assist at every step of the CT workflow, while reducing radiation dose and improving image quality for complex exams like cardiac imaging. Philips will also spotlight Spectral CT 7500, providing spectral CT solutions across a wide range of clinical areas including cardiology, oncology, neurology, musculoskeletal, and pediatrics. With more than 24 million spectral exams performed to date, Spectral CT 7500 has been shown to deliver up to 97% diagnostic sensitivity compared to 55% with conventional CT [6]; 96% certainty of cyst vs. lesion compared to 30% with conventional CT [7]; and a 26% reduction in follow-up scans due to incomplete diagnosis [8]. Philips is elevating image quality in ultrasound with the newest releases of its EPIQ Elite and Affiniti systems featuring new workflow and quantification automation to make exams faster and reproducible to help increase clinical confidence. With more than 100 optimized presets across multiple clinical applications, Philips' latest innovations in ultrasound help reduce exam times and variability. This is meant to increase efficiency with over 50% reduction in time for image optimization during abdominal and obstetrics exams [9]. Also showcased will be the latest Azurion 7 platform to support image-guided interventional procedures with a 17% reduction in procedure time and a 12% reduction in patient preparation time, bringing the ability to treat one more patient per day [10]. Expanded strategic collaboration with AWS At RSNA Philips will showcase its advanced Healthcare Informatics capabilities for data management, advanced visualization, automation, and AI to help reduce administrative burdens and empower clinicians with insights to deliver better care. In the run-up to the event, Philips expanded its strategic collaboration with Amazon Web Services (AWS) to offer Philips' integrated diagnostics portfolio in the cloud, including radiology, digital pathology, cardiology [11], and AI advanced visualization [11] solutions. As part of the agreement, Philips aims to create robust and scalable generative AI applications that leverage state-of-the-art foundation models from Amazon Bedrock, and seamlessly integrate into clinical workflows. Philips will also debut the latest 510(k) clearance of its Radiology Operations Command Center remote scanning and remote protocol management features [12] enabling real-time collaboration between imaging experts and on-site technologists, virtually anywhere, to help streamline radiology operations and workflows to provide high-quality imaging to more patients at lower costs. Paired with the world's first and only helium-free mobile MRI solution, Philips continues to expand quality care to large populations of traditionally underserved patients in a more accessible and sustainable way. Visit Philips at RSNA for more information. [1] 3 Key market trends source: The Burden of Chronic Disease (Karen Hacker); The healthcare data explosion (RBC Capital Markets); Radiologist burnout (Catalina imaging) [2] 3 Key market trends source: The Burden of Chronic Disease (Karen Hacker); The healthcare data explosion (RBC Capital Markets); Radiologist burnout (Catalina imaging) [3] Helium-free operations. 7 liters of helium is permanently enclosed in the cryogenic circuit. [4] BlueSeal XE/SE and Smart Reading are not yet CE marked, not cleared in all countries, and not yet available for delivery in any country. Please consult your Philips contact person for further information. [5] Compared to conventional 1.5T zero boil off systems in the industry BlueSeal MR system weight (with cryogen) 2,300 kg (5,071 lbs). [6] Mellander, et al. (Skåne University Hospital, Lund, Sweden), Acta Radiology (2022) DOI: 10.1177/02841851221130612 [7] Andersen MB, Ebbesen D, Thygesen J, Kruis M, Rasmussen F. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol. 2020 Oct;30(10):5539-5550. doi: 10.1007/s00330-020-06878-7 [8] Follow-up Recommendation Rates Associated with Spectral Detector Dual-Energy CT of the Abdomen and Pelvis: A Retrospective Comparison to Single-Energy CT. Atwi, Noah E. et al. J Am Coll Radiol. 2020;17:940-950 [9] D001833994, Marketing Claim Evidence for VM12.0 Workflow Efficiency Quick Launch Preset [10] Results from study conducted at St. Antonius Hospital. Results verified by NAMSA, independent third-party expert on study design and analytics. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. [11] Available on cloud in 2025. [11] Available on cloud in 2025. [12] Remote editing and protocol management are functionalities powered by the 510(k) cleared ROCC Console solution. ROCC Console is not to be used without a trained and qualified user at the scanner. For further information, please contact: Kathy O'Reilly Philips Global External Relations Tel.: +1 978-221-8919 E-mail : [email protected] About Royal Philips Royal Philips PHGPHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. Attachments philips-next-gen-blueseal-mri-2 ct-5300-product-image-2 next-gen-blueseal-mri-with-smart-reading PHGKoninklijke Philips NV$26.58-2.10%WatchlistOverviewMarket News and Data brought to you by Benzinga APIs

Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024 - Koninklijke Philips (NYSE:PHG)

December 1, 2024 Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more patients, including reading support with Automated AI-enabled Philips Advanced Visualization Workspace applicationsPhilips collaborates with Annalise.ai to evaluate streamlining workflows to prioritize time-sensitive cases Amsterdam, the Netherlands and Chicago, USA - Royal Philips PHGPHIA), a global leader in health technology, today announced a boost in confidence in clinical decision-support with AI and smart workflow automation capabilities in the company's recently introduced CT 5300 system, which is making its North America debut at RSNA 2024. Key to this latest innovation is Philips' CT Smart Workflow featuring a comprehensive suite of AI-enabled 'Precise' software solutions that assist at every step of the CT workflow, freeing technicians and radiologists from routine, time-consuming tasks and allowing them more time to focus on their patients. "By equipping the CT 5300 with our unique NanoPanel Precise detector and ultra-low noise Precise Image reconstruction technology, together with our latest AI-driven CT Smart Workflow solutions, we are integrating hardware, software, and AI to make high-quality care more productive, cost-effective, and widely accessible," said Dan Xu, CT Business Leader at Philips. "The productivity and diagnostic confidence enhancements that AI can deliver to CT imaging empower care teams and ease departmental workflow, helping to mitigate today's chronic shortage of highly skilled radiologists and technicians." End-to-end AI-driven smart workflow Philips CT Smart Workflow solutions include camera-based Precise Position, which improves the accuracy of vertical positioning relative to manual positioning by up to 50% during scan preparation, increases user-to-user consistency by up to 70%, and reduces positioning time by up to 23% [1]. Also included is Precise Cardiac, which compensates for cardiac motion to improve visualization of the coronary arteries during CT imaging, even in patients with a rapid heartbeat, and Precise Brain, which automatically reformats scans to help improve visualization for fast confident diagnosis of the respective anatomies. In addition, Precise Image delivers fast, high-quality image reconstruction with an 80% lower radiation dose, 85% lower noise, and 60% improved low-contrast detectability [2], making the CT 5300 ideal for sites developing cardiac programs and ultra-low dose screening. CT 5300 is seamlessly integrated with Advanced Visualization Workspace, Philips' comprehensive, scalable AI-enabled image post-processing platform [3,4]. This platform is designed to streamline radiology workflows to help deliver high-quality care, enhance diagnostic confidence, and speed image reading and reporting. The unique clinical depth and deployment capabilities of Advanced Visualization Workspace allow it to scale to meet changing clinical needs and future expansion. Collaboration with Annalise.ai for triage evaluation in emergency departments Philips also announced a pilot with medical imaging AI solutions company Annalise.ai to investigate the feasibility of Annalise Critical Care AI - a comprehensive critical case triage support solution - to enhance triage support and optimize workflows for conditions like traumatic brain injury (TBI), which require time-critical intervention. This newly announced collaboration aims to evaluate ways to further streamline workflows and prioritize time-sensitive cases. The collaboration will investigate integrating Annalise Critical Care AI - the most comprehensive AI-driven triage product for chest X-ray and non-contrast CT of the brain available in the USA. By flagging and prioritizing 12 time-sensitive clinical findings often encountered in emergency departments, these AI capabilities help clinicians focus on the most critical cases. This is particularly valuable during nights and weekends when fewer staff are on duty, and delays in intervention pose a significant risk to patients. "This is an exciting time for radiology. Our solutions are designed to streamline workflows and boost productivity for radiology teams. Together with Philips, we look forward to making high-quality care truly accessible," said Dimitry Tran, co-founder and deputy CEO of Annalise.ai. Critical Care AI has been shown to improve median report turnaround times by up to 39% [5]. It is the first computer-aided detection triage device to receive FDA Breakthrough Device Designation and secure NTAP (New Technology Add-on Payment) for obstructive hydrocephalus (water on the brain) detection. Philips will also be evaluating the Annalise Enterprise CTB solution - a comprehensive clinical decision-support solution that can detect up to 130 radiology findings - for sites outside of the USA. The Philips CT 5300 with Advanced Visualization Workspace will be showcased at the Philips Booth #6730 at #RSNA24. Visit Philips at RSNA for more information. [1] Based on an internal Philips assessment conducted by five clinical experts, comparing manual positioning versus Precise Position in 40 clinical cases using a human body phantom. [2] In clinical practice, the use of Precise Image may reduce CT patient dose depending on the clinical task, patient size, and anatomical location. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. Dose reduction assessments were performed using reference body protocols with 1.0 mm slices at the "Smoother" setting of Precise Image, and tested on the MITA CT IQ Phantom (CCT189, The Phantom Laboratory) assessing the 10 mm pin and compared to filtered-back projection. A range is seen across the four pins, using a channelized hoteling observer tool, that includes lower image noise by 85% and improved low-contrast detectability from 0% to 60% at 50% to 80% dose reduction. NPS curve shift is used to evaluate image appearance, as measured on a 20 cm water phantom in the center 50mm x 50 mm region of interest, with an average shift of 6% or less. [3] Specktor B. Preprocessing prediction of advanced algorithms for medical imaging, J Digit Imaging 31:42-50, 2018 [4] Applications may not be available in all markets. Please Contact your Philips representative for more details. [5] S. Karunasena, M. Milne, D. Rosewarne, C. Jones. Radiologist reporting productivity benefits from AI-assisted triage of CXR studies in clinical practice. Poster, British Institute of Radiology Annual Congress 2022. https://annalise.ai/evidence/radiologist-reporting-productivity-benefits-from-ai-assisted-triage-of-cxr-studies-in-clinical-practice/ For further information, please contact: Kathy O'Reilly Philips Global Press Office Tel.: +1 978-221-8919 E-mail : [email protected] About Royal Philips Royal Philips PHGPHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. Attachments Philips CT 5300 with AI-enabled workflow Clinical image of the heart with Precise Cardiac on Philips CT 5300 PHGKoninklijke Philips NV$27.240.33%WatchlistOverviewMarket News and Data brought to you by Benzinga APIs

Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24 - Koninklijke Philips (NYSE:PHG)

November 25, 2024 icometrix' FDA-cleared quantitative brain solution for neurological conditions including Alzheimer's and multiple sclerosis is seamlessly integrated into Philips next generation BlueSeal MR scanners, and will be deployed in its comprehensive informatics platform Amsterdam, the Netherlands and Leuven, Belgium - Royal Philips PHGPHIA), a global leader in health technology, and computer-aided diagnostics company icometrix (Leuven, Belgium) have teamed up to deploy an AI-driven, end-to-end solution for acquiring, reading, and reporting the results of MRI brain scans to optimize diagnosis and treatment monitoring of neurological conditions including Alzheimer's and multiple sclerosis (MS). Unveiled at RSNA 2024, icometrix's unique AI-powered quantitative reporting software is seamlessly integrated into Philips' latest BlueSeal MR scanners through Philips' new Smart Reading capability [1], providing consistent and more accurate diagnosis. The software will also be deployed on Philips' healthcare informatics platform - including Philips cloud-based AI Manager. The introduction of new drugs that slow the progression of Alzheimer's emphasizes the critical role of MRI in patient management. By leveraging advanced MRI techniques, neurologists can identify the most suitable candidates for these therapies, ensuring timely and personalized treatment. AI's ability to extract quantitative measurements from brain scans enhances the diagnostic process, enabling quicker decision making and improved monitoring of disease progression. This integration of technology increases efficiency for healthcare providers and leads to more tailored treatment. "Philips is at the forefront of applying AI to help save time and improve diagnostic accuracy so clinicians can deliver better care to more patients," said Shez Partovi, Chief Innovation & Strategy Officer at Philips. "As these innovations continue to evolve, they hold great promise for transforming the landscape of neurological care, offering hope for better management of chronic conditions like Alzheimer's and MS. Our partnership with icometrix is an important step forward in the use of AI to help mitigate staff shortages, lower the cost of care, increase diagnostic confidence, and facilitate care orchestration of personalized plans for the growing number of people who are diagnosed with Alzheimer's disease." "Our icobrain imaging AI measures are rapidly becoming the standard of care for diagnosis and monitoring of neurological conditions," said Wim Van Hecke, CEO of icometrix. "MRI quantification is crucial to unlock precision medicine, especially in the Alzheimer's disease care pathway, which is why our partnership with Philips is so well timed. We have developed the leading AI solutions for brain MRI monitoring, received CPT III code reimbursement in the US, and we will be able to support radiologists, neurologists, and people with neurological conditions at scale through this collaboration." Managing the growing volume of Alzheimer's imaging results Alzheimer's is the most common form of dementia, accounting for 60% to 70% of the 55 million dementia cases worldwide [2], with more than 150 million people likely to be living with dementia, predominantly Alzheimer's, by 2050 [3]. With the introduction of monoclonal antibody drugs that break down the amyloid protein deposits in the brain that are believed to be the cause of Alzheimer's, MRI is now crucial as a part of the diagnostics process as well as to assess treatment effectiveness and help avoid adverse side effects. The latest guidelines for using these drugs involve a minimum of four separate MRI scans during the first year of treatment. High caseloads and the global shortage of neuroradiologists - coupled with the time-consuming nature of manual image reading and difficulty in extracting consistent quantitative measurements - is already putting a severe burden on radiology departments. In addition to icometrix's icobrain dm software for differential dementia diagnosis, the solution also includes the company's icobrain ARIA software [4]. The only FDA-cleared solution that is classified as computer-aided detection and diagnosis, Icobrain ARIA can detect and grade the severity of amyloid-related imaging abnormalities. Icobrain ARIA quantifies, in a fully automated way, the extent of a potentially fatal side effect of anti-amyloid drugs known as amyloid-related imaging abnormalities (ARIA) - typically fluid buildup in the brain or blood leakage into brain tissue. Monitoring ARIA over the course of therapy allows neurologists to adjust a patient's therapy to minimize these side effects. Philips' latest BlueSeal MR scanners are delivered with standardized AI-based SmartExam planning and AI-accelerated SmartSpeed protocols to image ARIA quickly and easily. Philips unique Smart Reading software [4] also allows end-to-end seamless integration of imaging protocols with the icometrix icobrain ARIA software to deliver fast, fully automated, quantitative outcomes for Alzheimer's patients. Integrated into Philips' healthcare informatics platform, these breakthrough AI-driven diagnostic and therapy monitoring capabilities fit seamlessly into radiology MR workflows and hospital PACS. Speeding the differential diagnosis of multiple sclerosis To ensure more confident diagnosis of MS, new clinical guidelines have been introduced that include a special MR imaging protocol and FLAIR* generation in Philips Advanced Visualization Workspace to simultaneously create high-quality images of white matter lesions and veins. Philips is currently the only commercial supplier of MR scanners that can perform FLAIR* imaging. icometrix icobrain ms, also seamlessly integrates on the Philips MR scanner and Philips AI Manager. It counts the number of white-matter lesions forming around veins - a characteristic highly specific to MS and it also allows for longitudinal and quantitative comparison of follow-up MRI exams, which are essential for treatment decision-making. Philips' latest neuroimaging solutions and icometrix's software solutions for Alzheimer's and MS will be available on the Philips BlueSeal 1.5T MR scanners and Philips' 3.0T MR portfolio. The solutions will be demonstrated in the Philips booth (6730) and the icometrix booth (4903) at the Radiological Society of North America Annual Meeting (RSNA 2024, December 1-4, Chicago, USA). For more information, visit Philips at RSNA 2024. [1] BlueSeal XE/SE and Smart Reading is not yet CE marked, not cleared in all countries, and not yet available for delivery in any country. Please consult your Philips contact person for further information. [2] World Health Organization (WHO), Dementia Key Facts https://www.who.int/news-room/fact-sheets/detail/dementia [3] Nichols, Emma et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health, Volume 7, Issue 2, e105 - e125 https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00249-8/fulltext [4] Philips and Icometrix have the intention to make icobrain aria software available for reselling in the USA through the Philips catalog, as well as a Smart Reading solution on MR platforms. Philips AI Manager is not intended for data interpretation or diagnosis. Availability of 3rd party algorithm may vary per market. The functionalities and benefits of the solution depend on customer-specific configuration and use. Please contact your local Philips representative for market availability. For further information, please contact: Kathy O'Reilly Philips Global External Relations Tel.: +1 978 221 8919 E-mail: [email protected] About Royal Philips Royal Philips PHGPHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. Attachments MR technologist reviews icometrix AI report on the Philips BlueSeal MRI console MR technologist reviews neuro images in icometrix AI reporting tool Market News and Data brought to you by Benzinga APIs

Philips and AWS expand strategic collaboration to advance HealthSuite cloud services and power generative AI workflows - Koninklijke Philips (NYSE:PHG)

November 26, 2024 Cloud-enabled integrated diagnostics portfolio aims to unify workflows, improve access to critical insights, and drive better outcomes for patients Amsterdam, the Netherlands - Royal Philips PHGPHIA), a global leader in health technology, today announced the expansion of its strategic collaboration with Amazon Web Services (AWS) to offer Philips' integrated diagnostics portfolio in the cloud, including radiology, digital pathology, cardiology [1], and AI advanced visualization [1] solutions. The collaboration aims to unify diagnostic workflows, improving access to critical insights and driving better outcomes across clinical specialties. Philips has already successfully transitioned over 150 sites across North America and Latin America to Philips HealthSuite Imaging on AWS and is building on its collaboration with AWS to accelerate the migration of health systems to the cloud, and will expand to include customer cloud migrations in Europe. Cloud Capabilities for Integrated Diagnostics Philips offers scalable healthcare informatics solutions by leveraging industry-leading cloud availability, reliability and security from AWS. Philips' cloud-based solutions will offer a unified view of patient data from diverse diagnostic sources, including radiology images, digital pathology slides, and other clinical records to support care team collaboration and optimize workflows. Clinicians also benefit from remote access to diagnostic, reporting, and workflow orchestration tools, which can enhance diagnostic capabilities across healthcare imaging, from diagnosis to treatment and follow-up. "The collaboration between Philips and AWS gives healthcare providers scalable, secure-by-design cloud-enabled solutions to accelerate healthcare innovation," said Matt Garman, CEO of AWS. "Combining Philips' healthcare informatics portfolio with AWS generative AI capabilities gives clinicians access to imaging insights so they can deliver more effective and efficient care to patients anywhere, anytime, with best-in-class security and privacy." The Future of Workflows with Generative AI As healthcare providers continue to face significant challenges, Philips works closely with clinicians to develop innovative ways to address the increasing clinical demands. By automating routine tasks and optimizing workflows, clinicians would be able to dedicate more time to image interpretation, consultations, and patient interactions. Philips aims to create robust and scalable generative AI applications that leverage state-of-the-art foundation models from Amazon Bedrock, and seamlessly integrate into clinical workflows. In the future, these AI applications may reduce administrative burdens and time-consuming repetitive tasks, helping clinicians focus their expertise where it matters most - in critical decision-making. One example of how Philips is exploring generative AI as part of its innovation roadmap is through conversational reporting, allowing clinicians to use conversational language to convert findings into structured reports, which can then be reviewed. These capabilities can help construct and revise reports in real-time, add diagnostic impressions, and flag potential inconsistencies. Generative AI has the potential to reduce report editing time, while maintaining high quality by integrating patient histories and clinical context into the final diagnostic report. Optimized reporting could help lead to quicker diagnosis and support better overall quality of care. "Given the tremendous increase not only in patient volumes, but also in the complexity and number of images per study, radiologists need a tool that limits the distractions of dictation while at the same time increasing accuracy," said Edward Steiner, Chief and Medical Director, The York/WellSpan Advanced Prostate Care Center, USA. "With Philips' concept of ambient reporting using generative AI, you simply could speak in a conversational tone and a structured report is generated within seconds. My estimate is a 15 to 20 percent increase in efficiency, and this is just the start." "Philips' cloud-based healthcare informatics solutions allow us to drive better outcomes across clinical disciplines, including radiology, digital pathology and cardiology. We're working closely with clinicians to ensure workflows become more efficient and give back valuable time to healthcare providers," said Roy Jakobs, CEO of Royal Philips. "Collaborating with AWS helps us to innovate faster and deliver better care for more people." Healthcare Informatics at RSNA Philips will showcase its latest informatics solutions in the Philips booth (#6730) at the Radiological Society of North America Annual Meeting, Dec. 1-4, 2024, in Chicago, USA. For more information, visit Philips at RSNA 2024. [1] Available on cloud in 2025. For further information, please contact: Anna Hogrebe Philips Global External Relations Tel.: +1 416 270 6757 E-mail: [email protected] About Royal Philips Royal Philips PHGPHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. Attachments Radiologist looking at lung CT scan Oncologist and radiologist reviewing scans Market News and Data brought to you by Benzinga APIs